| Literature DB >> 26426545 |
Silvia Fernicola1, Ilaria Torquati2, Alessandro Paiardini3, Giorgio Giardina1, Giordano Rampioni4, Marco Messina4, Livia Leoni4, Fabio Del Bello2, Riccardo Petrelli2, Serena Rinaldo1, Loredana Cappellacci2, Francesca Cutruzzolà1.
Abstract
Cyclic di-GMP (c-di-GMP) is a widespread second messenger that plays a key role in bacterial biofilm formation. The compound's ability to assume multiple conformations allows it to interact with a diverse set of target macromolecules. Here, we analyzed the binding mode of c-di-GMP to the allosteric inhibitory site (I-site) of diguanylate cyclases (DGCs) and compared it to the conformation adopted in the catalytic site of the EAL phosphodiesterases (PDEs). An array of novel molecules has been designed and synthesized by simplifying the native c-di-GMP structure and replacing the charged phosphodiester backbone with an isosteric nonhydrolyzable 1,2,3-triazole moiety. We developed the first neutral small molecule able to selectively target DGCs discriminating between the I-site of DGCs and the active site of PDEs; this molecule represents a novel tool for mechanistic studies, particularly on those proteins bearing both DGC and PDE modules, and for future optimization studies to target DGCs in vivo.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26426545 DOI: 10.1021/acs.jmedchem.5b01184
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446